{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T07:41:28Z","timestamp":1771746088920,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.trim.2022.101771","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:26:34Z","timestamp":1670246794000},"page":"101771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes"],"prefix":"10.1016","volume":"76","author":[{"given":"Zulaika","family":"Grille-Cancela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Barge-Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Su\u00e1rez-Fuentetaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Domenech-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Paniagua-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Barge-Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Couto-Mall\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Enr\u00edquez-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Blanco-Canosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Pombo-Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"V\u00e1zquez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda G.","family":"Crespo-Leiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.trim.2022.101771_bb0005","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1073\/pnas.89.9.3947","article-title":"Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens","volume":"89","author":"Ishitani","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.trim.2022.101771_bb0010","first-page":"837","article-title":"Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term","volume":"318","author":"Moreau","year":"1995","journal-title":"C R Acad. Sci. III."},{"issue":"3","key":"10.1016\/j.trim.2022.101771_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","article-title":"HLA-G: from biology to clinical benefits","volume":"29","author":"Carosella","year":"2008","journal-title":"Trends Immunol."},{"issue":"9221","key":"10.1016\/j.trim.2022.101771_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(00)02386-2","article-title":"Implication of HLA-G molecule in heart-graft acceptance","volume":"355","author":"Lila","year":"2000","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.trim.2022.101771_bb0025","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000015075.89984.46","article-title":"Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection","volume":"105","author":"Lila","year":"2002","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.trim.2022.101771_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-6143.2003.30103.x","article-title":"HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?","volume":"3","author":"Rouas-Freiss","year":"2003","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2022.101771_bb0035","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.healun.2021.07.015","article-title":"The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult heart transplantation report - 2021; focus on recipient characteristics","volume":"40","author":"Khush","year":"2021","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.trim.2022.101771_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"12","key":"10.1016\/j.trim.2022.101771_bb0045","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.4049\/jimmunol.164.12.6100","article-title":"Cutting edge: soluble HLA-G1 triggers CD95\/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8","volume":"164","author":"Fournel","year":"2000","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.trim.2022.101771_bb0050","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1073\/pnas.201407398","article-title":"Soluble HLA-G protein secreted by Allo-specific CD4+ T cells suppresses the Allo-proliferative response: a CD4+ T cell regulatory mechanism","volume":"98","author":"Lila","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.trim.2022.101771_bb0055","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.trim.2022.101771_bb0060","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0198-8859(00)00197-X","article-title":"Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, \u2212G6, and -G7 transcripts in human transfected cells","volume":"61","author":"Paul","year":"2000","journal-title":"Hum. Immunol."},{"issue":"11","key":"10.1016\/j.trim.2022.101771_bb0065","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.humimm.2003.08.356","article-title":"Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients","volume":"64","author":"Creput","year":"2003","journal-title":"Hum. Immunol."},{"issue":"11","key":"10.1016\/j.trim.2022.101771_bb0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.186.11.1809","article-title":"A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells","volume":"186","author":"Colonna","year":"1997","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.trim.2022.101771_bb0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00018-010-0581-6","article-title":"HLA-G in organ transplantation: towards clinical applications","volume":"68","author":"Deschaseaux","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"4\u20135","key":"10.1016\/j.trim.2022.101771_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.humimm.2006.02.034","article-title":"Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy","volume":"67","author":"Luque","year":"2006","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2022.101771_bb0085","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.transproceed.2012.01.141","article-title":"Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation","volume":"44","author":"Jin","year":"2012","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2022.101771_bb0090","doi-asserted-by":"crossref","first-page":"4326495","DOI":"10.1155\/2016\/4326495","article-title":"Recent advances in our understanding of HLA-G biology: lessons from a wide Spectrum of human diseases","volume":"2016","author":"Morandi","year":"2016","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.trim.2022.101771_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2217\/fmb.15.143","article-title":"HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"11","author":"Rizzo","year":"2016","journal-title":"Future Microbiol."},{"key":"10.1016\/j.trim.2022.101771_bb0100","doi-asserted-by":"crossref","first-page":"3890306","DOI":"10.1155\/2016\/3890306","article-title":"Study of soluble HLA-G in congenital human cytomegalovirus infection","volume":"2016","author":"Rizzo","year":"2016","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.trim.2022.101771_bb0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semcancer.2007.06.014","article-title":"HLA-G and cancer","volume":"17","author":"Carosella","year":"2007","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.trim.2022.101771_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-0039.2011.01716.x","article-title":"Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer","volume":"78","author":"Cao","year":"2011","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.trim.2022.101771_bb0115","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J. Heart Lung Transplant."},{"issue":"1, Supplement","key":"10.1016\/j.trim.2022.101771_bb0120","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/S1053-2498(02)00897-5","article-title":"Scoring of 2,788 endomyocardial biopsies correlate rejection to the development of transplant coronary artery disease after heart transplantation","volume":"22","author":"Espejo Vassilakis","year":"2003","journal-title":"J. Heart Lung Transplant."},{"issue":"7","key":"10.1016\/j.trim.2022.101771_bb0125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010","volume":"29","author":"Mehra","year":"2010","journal-title":"J. Heart Lung Transplant."},{"issue":"3","key":"10.1016\/j.trim.2022.101771_bb0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am. J. Infect. Control"},{"issue":"5","key":"10.1016\/j.trim.2022.101771_bb0135","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0041-1345(03)00656-0","article-title":"Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring","volume":"35","author":"Aumente Rubio","year":"2003","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.trim.2022.101771_bb0140","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.humimm.2011.08.016","article-title":"Human leukocyte antigen-G is upregulated in heart failure patients: a potential novel biomarker","volume":"72","author":"Almasood","year":"2011","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2022.101771_bb0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.healun.2008.02.004","article-title":"Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients","volume":"27","author":"Sheshgiri","year":"2008","journal-title":"J. Heart Lung Transplant."},{"issue":"9","key":"10.1016\/j.trim.2022.101771_bb0150","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1600-6143.2006.01417.x","article-title":"Soluble HLA-G expression and renal graft acceptance","volume":"6","author":"Qiu","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2022.101771_bb0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ajt.12977","article-title":"Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study","volume":"15","author":"Brugiere","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2022.101771_bb0160","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.4049\/jimmunol.176.5.3266","article-title":"Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive\/ regulatory T cells","volume":"176","author":"Le Rond","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2022.101771_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0039.2006.00757.x","article-title":"Research on HLA-G: an update","volume":"69","author":"Favier","year":"2007","journal-title":"Tissue Antigens"},{"issue":"7","key":"10.1016\/j.trim.2022.101771_bb0170","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.healun.2011.01.726","article-title":"The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients","volume":"30","author":"Twito","year":"2011","journal-title":"J. Heart Lung Transplant."},{"issue":"3","key":"10.1016\/j.trim.2022.101771_bb0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00251-004-0673-2","article-title":"HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms","volume":"56","author":"Hviid","year":"2004","journal-title":"Immunogenetics."},{"issue":"5","key":"10.1016\/j.trim.2022.101771_bb0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/0961203308098187","article-title":"Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus","volume":"18","author":"Veit","year":"2009","journal-title":"Lupus."},{"issue":"4","key":"10.1016\/j.trim.2022.101771_bb0185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0039.2008.01107.x","article-title":"The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma","volume":"72","author":"Chen","year":"2008","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.trim.2022.101771_bb0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.trim.2007.10.010","article-title":"Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection","volume":"18","author":"Crispim","year":"2008","journal-title":"Transpl. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2022.101771_bb0195","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.transproceed.2005.12.108","article-title":"Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation","volume":"38","author":"Basturk","year":"2006","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.trim.2022.101771_bb0200","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.healun.2009.07.009","article-title":"Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients","volume":"28","author":"Sheshgiri","year":"2009","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.trim.2022.101771_bb0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.humimm.2019.10.003","article-title":"Soluble HLA-G pre-transplant levels to identify the risk for development of infection in heart transplant recipients","volume":"81","author":"Bortolotti","year":"2020","journal-title":"Hum. Immunol."},{"issue":"11","key":"10.1016\/j.trim.2022.101771_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112338","article-title":"Recipient HLA-G +3142 CC genotype and concentrations of soluble HLA-G impact on occurrence of CMV infection after living-donor kidney transplantation","volume":"18","author":"Guberina","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.trim.2022.101771_bb0215","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.humimm.2012.12.001","article-title":"Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy","volume":"74","author":"Blanco-Garc\u00eda","year":"2013","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2022.101771_bb0220","doi-asserted-by":"crossref","first-page":"S298","DOI":"10.1016\/j.healun.2013.01.848","article-title":"Human leukocyte antigen-G inhibits human coronary artery smooth muscle cell proliferation","volume":"32","author":"Mociornita","year":"2013","journal-title":"J. Heart Lung Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422002453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422002453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:03:02Z","timestamp":1760810582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327422002453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":44,"alternative-id":["S0966327422002453"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2022.101771","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2022.101771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101771"}}